Checkpoint Therapeutics Inc

Checkpoint Therapeutics Inc company information, Employees & Contact Information

Checkpoint Therapeutics is revolutionizing the way novel treatments for cancer patients are developed. As a fast-follower, our streamlined approach lowers risk and accelerates the development and commercialization of oncology drugs, ensuring more patients, payors and providers benefit from effective and more affordable treatment options.

Company Details

Employees
24
Founded
-
Address
95 Sawyer Rd,
Phone
781-652-4500
Email
in****@****ttx.com
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Waltham, Massachusetts
Looking for a particular Checkpoint Therapeutics Inc employee's phone or email?

Checkpoint Therapeutics Inc Questions

News

Checkpoint Therapeutics Announces FDA Approval of UNLOXCYT™ (cosibelimab-ipdl) - GlobeNewswire

Checkpoint Therapeutics Announces FDA Approval of UNLOXCYT™ (cosibelimab-ipdl) GlobeNewswire

Checkpoint Therapeutics Reports First Quarter Financial Results and Recent Corporate Updates - Yahoo Finance

Checkpoint Therapeutics Reports First Quarter Financial Results and Recent Corporate Updates Yahoo Finance

FDA Approves Cosibelimab for Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma - OncLive

FDA Approves Cosibelimab for Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma OncLive

Checkpoint Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference - Stock Titan

Checkpoint Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference Stock Titan

Checkpoint Therapeutics Announces Cosibelimab Longer-Term Results in Advanced Cutaneous Squamous Cell Carcinoma Presented at ESMO Congress 2024 - Yahoo Finance

Checkpoint Therapeutics Announces Cosibelimab Longer-Term Results in Advanced Cutaneous Squamous Cell Carcinoma Presented at ESMO Congress 2024 Yahoo Finance

Checkpoint Therapeutics Announces Exercise of Warrants for $11.13 Million in Gross Proceeds - Stock Titan

Checkpoint Therapeutics Announces Exercise of Warrants for $11.13 Million in Gross Proceeds Stock Titan

Checkpoint Therapeutics Reports Preclinical Data on BET - GlobeNewswire

Checkpoint Therapeutics Reports Preclinical Data on BET GlobeNewswire

Checkpoint Therapeutics Receives Pediatric Investigational Plan Waivers for Cosibelimab from the European Medicines Agency and U.K. Medicines & Healthcare Products Regulatory Agency - Yahoo Finance

Checkpoint Therapeutics Receives Pediatric Investigational Plan Waivers for Cosibelimab from the European Medicines Agency and U.K. Medicines & Healthcare Products Regulatory Agency Yahoo Finance

GC Cell and Checkpoint Therapeutics Advance Collaborative Cancer Research - Stock Titan

GC Cell and Checkpoint Therapeutics Advance Collaborative Cancer Research Stock Titan

Top Checkpoint Therapeutics Inc Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant